Diss-appointing to see sellers at 2c after a positive announcement but there are buyers for 6 million against sellers of 260K. The continued progression of the cell line is impressive to me especially the reduction in production cost. Somehow I think that the Anavex 2.73A by KaRaMINDS Institute ( I could have this a tad wrong, it could be Anavex their symbol is AVXL) would benefit greatly by being able to utilise the blood brain barrier penetration/crossing capabilities of PAB.
Ann: Appendix 4C - Quarterly - 31 December 2019, page-7
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
